What is CAR T?
CAR T in autoimmune
What to expect
BMS CAR T studies
Header Image of a Cell

 

CAR T cell therapy is a
personalized treatment
given as a one-time infusion

When a person chooses to receive CAR T cell therapy,
their treatment is made specifically for them, from their own T cells.

 

The CAR T cell treatment process has been proven by years of experience

A pioneer in CAR T cell therapy, Bristol Myers Squibb has more than 20 years of experience in this field. CAR T cell therapy is not yet approved to treat autoimmune diseases. It is only available to people with autoimmune diseases in clinical studies.

But for other conditions, CAR T cell therapy was first given to patients in a clinical study in 2011. Since then, it has been prescribed for thousands of patients around the world.

There are 3 main steps to CAR T cell therapy

CAR T cell therapy is given at a certified treatment center. Completing all 3 steps takes several visits. At the center, you will be cared for by an experienced team and may also see several specialists.

STEP 1: Before CAR T cell treatment

Blood collection

The patient’s blood is taken through a process called apheresis. The T cells are collected, and the other parts of the blood are returned to the patient’s body.

CAR T cell creation

The patient’s T cells are sent to a manufacturing facility where CARs are added. They are now CAR T cells with the power to find and destroy specific cells, which may include overactive and healthy cells.

Preparing for CAR T cell therapy

Before receiving CAR T cells, the patient receives a pre-infusion treatment to help prepare their body for treatment.

STEP 2: Treatment day

One-time CAR T cell therapy infusion

The patient’s CAR T cells are returned to their body as a one-time infusion.

STEP 3: After treatment

Monitoring

After the infusion of CAR T cells, the patient is closely monitored for side effects by the healthcare team at the certified center. After CAR T cell treatment is completed, long-term care may be overseen by the healthcare provider who originally referred the patient for CAR T cell therapy. Patients who receive CAR T cell therapy should be monitored over the long term for disease control and potential side effects. Throughout, the patient's support team and care partner also help to keep an eye on how the patient is doing.